With Two Potential First-in-class Innovative Drugs' Commercialization around the Corner, RemeGen is Expected to Explode upon Listing
- Written by ACN Newswire
HONG KONG, Nov 6, 2020 - (ACN Newswire) - According to Bloomberg, recent years have seen the strong performance of biopharmaceutical enterprises in Hong Kong stock market. Bonnie Chan, Head of Listing of HKEX, said at the HKEX Biotech Summit on 1st September this year that 20 pre-revenue biotechnology companies had been listed in Hong Kong by...